AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2024
May 9, 2024
34491_dirs_2024-05-08_ef6cce79-2fed-4729-bde9-4e6d2dc9c3cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2024-05-08
Reporting Person: Kelly John Alexander (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-08 | Common Stock | A | 8334 | $12.00 | Acquired | 31014 | Direct |
Footnotes
F1: Represents shares purchased through a definitive subscription agreement, pursuant to which the Issuer agreed to issue and sell shares of its common stock in a non-brokered private placement to certain members of its management.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19